Načítá se...
Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report
RATIONALE: Blastic plasmacytoid dendritic cell neoplasm (BPDCN), derived from precursors of plasmacytoid dendritic cells, is a rare and aggressive malignancy with frequent cutaneous involvement. Although cutaneous lesions are often chemosensitive, BPDCN portends a poor prognosis as most patients rel...
Uloženo v:
Vydáno v: | Medicine (Baltimore) |
---|---|
Hlavní autoři: | , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Wolters Kluwer Health
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5758283/ https://ncbi.nlm.nih.gov/pubmed/29390581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000009452 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|